PARP-INHIBITORS CAN BE APPLIED TOGETHER WITH TUMOR TREATING FIELDS (TTFIELDS) TO PROLONG SURVIVAL IN AN OVARIAN CANCER MOUSE MODEL

被引:0
|
作者
Berckmans, Yani [1 ]
Wouters, Roxanne [1 ,2 ]
Thirion, Gitte [1 ]
Vandenbrande, Katja [1 ]
Vergote, Ignace [3 ]
Coosemans, An [1 ]
机构
[1] Lab Tumor Immunol & Immunotherapy, Leuven, Belgium
[2] Oncoinvent AS, Oslo, Norway
[3] Katholieke Univ Leuven, Div Gynaecol Oncol, UZ Leuven, Leuven, Belgium
关键词
D O I
10.1136/ijgc-2023-ESGO.585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
471
引用
收藏
页码:A282 / A282
页数:1
相关论文
共 32 条
  • [1] Preclinical efficacy of Tumor Treating Fields (TTFields) applied with PARP inhibitors or carboplatin in ovarian cancer
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Frechtel-Gerzi, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (01)
  • [2] Preclinical effects of Tumor Treating Fields (TTFields) with PARP inhibitors in ovarian cancer
    Berckmans, Yani
    Ene, Hila
    Ben-Meir, Kerem
    Martinez-Conde, Antonia
    Monin, Roni
    Van den Ende, Bieke
    Van Mechelen, Sara
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Vergote, Ignace
    Coosemans, An
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Tumor Treating Fields (TTFields) together with PARP inhibitors for treatment of pancreatic cancer cells
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Dor-On, Eyal
    Lamichhane, Puru
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (02)
  • [4] Tumor Treating Fields (TTFields) Concomitant with PARP Inhibitors for Treatment of Ovarian Cancer Cell Lines
    Martinez-Conde, A.
    Frechtel-Gerzi, R.
    Ene, H.
    Dor-On, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E276 - E276
  • [5] Tumor treating fields (TTFields) concomitant with PARP inhibitors or carboplatin for treatment of ovarian cancer cell lines
    Martinez-Conde, Antonia
    Ene, Hila
    Frechtel-Gerzi, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Concomitant treatment of ovarian cell lines with Tumor Treating Fields (TTFields) and PARP inhibitors
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
    Ene, Hila
    Ben Meir, Kerem
    Martinez-Conde, Antonia
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Gerasimova, Daria
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Efficacy of combining tumor treating fields (TTFields) with a PARP inhibitor in ovarian cell lines
    Mulvey, Brett
    Martinez-Conde, Antonia
    Efimov, Vera
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S158 - S158
  • [9] Tumor treating fields (TTFields) induce an anti-tumor immune response in a pancreatic cancer mouse model
    Kan, Tal
    Khalil, Tharwat Haj
    Barsheshet, Yiftah
    Voloshin, Tali
    Vorontsov, Avital
    Brant, Boris
    Koren, Lilach
    Blatt, Roni
    Cahal, Shay
    Zemer-Tov, Efrat
    Paz, Rom
    Klein-Goldberg, Anat
    Brami, Catherine Tempel
    Jacobovitch, Sara
    Volodin, Alexandra
    Koltun, Bella
    David, Cfir
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
    Frechtel-Gerzi, Roni
    Gerasimova, Daria
    Zeevi, Einav
    Monin, Roni
    Fishman, Hila
    Schlachet-Drukerman, Inbar
    Mumblat, Helena
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Palmer, Greg
    Secord, Angeles A.
    CANCER RESEARCH, 2024, 84 (01)